+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the safety and immune system effects of Spirulina Blue Protein capsules in healthy adults aged 25 to 60 years. This randomized, double-blind, placebo-controlled trial aims to better understand the potential immune benefits and safety of Spirulina Blue Protein, which has shown antioxidant, anti-inflammatory, and immune-modulating effects in preclinical studies but lacks sufficient human evidence. Participants will be randomly assigned to one of three groups placebo, 200 mgday Spirulina Blue Protein, or 1,000 mgday Spirulina Blue Protein capsules taken orally once daily for 12 weeks. The study will compare these groups to assess immune cell changes and cytokine levels, with interventions delivered in a parallel design over the 12-week period. During the study, participants will undergo blood sampling before and after treatment to measure immune cells like CD4, CD8, and natural killer cells, as well as cytokines such as IL-2, IL-6, IFN-, and TNF-. Safety will be monitored through vital signs, blood counts, liver and kidney tests, and tracking of any adverse events. The total participation time includes the 12-week treatment and assessments to evaluate immune function and tolerability.

Age: 25Years - 60YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating whether a higher dose of cetirizine can relieve symptoms of acute urticaria hives faster than the standard dose in adults aged 18 to 60. Acute urticaria causes sudden wheals and intense itching, impacting comfort and daily life. Many people do not fully improve with the standard dose and may be prescribed corticosteroids, which can cause side effects. This trial aims to find out if increasing cetirizine to 40 mg daily is more effective and safe compared to the usual 10 mg dose. Participants are randomly assigned to one of two groups one taking the standard dose of cetirizine 10 mg once daily, and the other taking a higher dose of 20 mg twice daily total 40 mg for 7 days. Both doses are given as capsules that look alike to keep the study unbiased. Participants will record their daily symptoms, including itch and hive severity, and attend follow-up visits on Day 3, Day 7, and Week 6. Blood tests will be done before and after treatment to monitor liver and kidney function. During the study, researchers will assess how quickly symptoms resolve and changes in urticaria severity scores. They will also track the use of corticosteroids as rescue medication, quality of life changes, and any side effects experienced. Follow-up visits will check for symptom recurrence or progression to chronic urticaria. The study lasts about 6 weeks from the first dose, including treatment and follow-up, to understand both short-term effects and safety of higher dose cetirizine.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
1 location
P

Actively Recruiting

Researchers are evaluating doravirine as an alternative to dolutegravir in people newly diagnosed with HIV-1 infection who have not yet received treatment. This Phase III, open-label, randomized clinical trial aims to determine if doravirine combined with tenofovir and lamivudine is not less effective than dolutegravir combined with tenofovir and lamivudine or emtricitabine. The study will be conducted across multiple countries including Brazil, Cameroon, Cte dIvoire, France, Mozambique, and Thailand, enrolling 610 participants. Participants will be randomly assigned to one of two groups one receiving doravirine 100 mg plus tenofovir DF 300 mg and lamivudine 300 mg daily, and the other receiving dolutegravir 50 mg plus tenofovir DF 300 mg and either lamivudine or emtricitabine daily. The treatment period will last for 96 weeks after starting antiretroviral therapy ART, with primary assessment at week 48 to measure viral suppression. During the study, participants will undergo evaluations to monitor viral load, drug resistance, metabolic health, body weight changes, liver and kidney function, cardiovascular status, and mental health. Adherence to ART will be tracked, and blood samples will be taken to measure drug levels and immune cell counts. The research team will review virological efficacy and safety outcomes at weeks 48 and 96, supporting a comprehensive understanding of the treatments effects over nearly two years of participation.

Age: 18Years +All GendersPhase 3
19 locations
S

Actively Recruiting

Healthy Volunteer

Overweight and obesity can impair breathing mechanics by reducing chest wall and diaphragmatic movement, weakening respiratory muscles, and causing inefficient breathing patterns. These changes may negatively affect lung function, autonomic nervous system control, and physical ability. This research aims to compare the effects of kettlebell swing exercise combined with breathing training versus breathing training alone in young adults with overweight or obesity, focusing on respiratory and cardiometabolic health outcomes. The study will include 40 young adults aged 18 to 25 years with a body mass index BMI of 23.0 kgm or higher. Participants will be randomly assigned to either an experimental group performing kettlebell swing exercises combined with breathing training for 40 minutes per session, three times a week, or a control group performing breathing training alone for 20 minutes per session, three times a week. This intervention will last for 6 weeks. During the study, participants will undergo assessments before and after the 6-week intervention to measure respiratory muscle strength, pulmonary function, heart rate variability, and body composition. These evaluations will help understand the impact of the combined training on respiratory and cardiovascular health. The total participation duration is 6 weeks, and the study includes monitoring and measuring key health indicators related to breathing and body composition.

Age: 18Years - 25YearsAll GendersPhase Not Applicable
1 location